ketorolac trometamol rompharm 5 mg/ml
s.c. rompharm company s.r.l - romania - ketorolacum tromethamin - pic. oft., sol. - 5mg/ml - antiinflamatoare antiinflamatoare nesteroidiene
tobrex 3 mg/ml picături oftalmice, soluţie
novartis pharma ag - tobramycinum - picături oftalmice, soluţie - 3 mg/ml
indocollyre 1 mg/ml
laboratoire chauvin - franta - indometacinum - picaturi oft., sol. - 1mg/ml - antiinflamatoare antiinflamatoare nesteroidiene
betoptic s 2,5 mg/ml
alcon couvreur n.v. - belgia - betaxololum - picaturi oft., susp. - 2,5mg/ml - antiglaucomatoase si miotice medicamente betablocante
isotretinoin bailleul 10 mg
gap s.a. - grecia - isotretinoinum - caps. moi - 10mg - preparate de uz sistemic pt. trat. acneei retinoizi pentru tratamentul acneei
isotretinoin bailleul 20 mg
gap s.a. - grecia - isotretinoinum - caps. moi - 20mg - preparate de uz sistemic pt. trat. acneei retinoizi pentru tratamentul acneei
combigan 2 mg/ml + 5 mg/ml
allergan pharmaceuticals ireland - irlanda - combinatii (brimonidinum+timololum) - pic. oft., sol. - 2mg/ml+5mg/ml - antiglaucomatoase si miotice agenti betablocanti
yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmologice - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
pegnano solutie injectabila in seringa preumpluta 180 mcg/0,5 ml
nanogen pharmceutical biotechnology company ltd. - peginterferon alfa-2a - solutie injectabila in seringa preumpluta - 180 mcg/0,5 ml
slezol forte picaturi oftalmice, solutie 1 mg/3 mg/ml
world medicine ophthalmics - dextranum + hypromellosum - picaturi oftalmice, solutie - 1 mg/3 mg/ml